Cure Arthritis Naturally

Cure Arthritis Naturally

Get Instant Access

56. Tanaka, H., Abe, E., Miyaura, C., Kuribayashi, T., Konno, K., Nishii, Y., and Suda, T., 1 a,25-dihydroxycholecalciferol and a human myeloid leukaemia cell line, Bio-chem. J., 1982; 204: 713-719.

57. Abe, E., Shiina, Y., Miyaura, C., Tanaka, H., Hayashi, T., Kanegasaki, S., Saito, M., Nishii, Y., DeLuca, H.F., and Suda, T., Activation and fusion induced by 1,25-dihydroxyvitamin D3 and their relation in alveolar macrophages, Proc. Natl. Acad. Sci. U.S.A., 1984; 81: 7112-7116.

58. Bhalla, A.K., Amento, E.P., and Krane, S.M., Differential effects of 1,25-dihydrox-yvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of inter-leukin-2 and augmentation of interleukin-2 and augmentation of interleukin-1 production, Cell. Immunol., 1986; 98: 311-322.

59. Kragballe, K., The future of vitamin D in dermatology, J. Am. Acad. Dermatol., 1997; 37: S72-S76.

60. Bhalla, A.K., Amento, E.P., and Clemens, T.L., Specific high affinity receptors for 1,25 dihydroxy vitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T-lymphocytes following activation, J. Clin. Endocrinol. Metab., 1983; 57: 1308-1310.

61. Rigby, W.F.C. and Waugh, M.G., Decreased accessory cell function and costimulatory activity by 1,25 dihydroxyvitamin D3 treated monocytes, Arthritis Rheum., 1992; 35: 110-119.

62. Gniadecki, R., Gniadecki, M., and Serup, J., Inhibition of glucocorticoid-induced epidermaland dermal atrophy with KH 1060 — a potent 20-epi analogue of 1,25 dihydroxyvitamin D3, Br. Med. Pharmacol., 1994; 113: 439-444.

63. Bikle, D.D. and Pillai, S., Vitamin D, calcium and epidermal differentiation, Endocr. Rev., 1993; 14: 3-19.

64. Chen, T.C., Persons, K., Uskokovic, M.R., Horst, R.L., and Holick, M.F., An evaluation of 1,25-dihydroxyvitamin D3 analogues on the proliferation and differentiation of cultured human keratinocytes, calcium metabolism and the differentiation of human HL-60 cells, J. Nutr. Biochem., 1993; 4: 49-57.

65. Bikle, D.D., Pillai, S., Gee, E., and Hincenbergs, M., Regulation of 1,25-dihydrox-yvitamin D production in human keratinocytes by interferon-gamma, Endocrinology, 1989; 124: 655-660.

66. Smith, E.L., Walworth, N.C., and Holick, M.F., Effect of 1 a,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions, J. Invest. Dermatol., 1986; 86: 709-714.

67. Lutzow-Holm, C., DeAngelis, P., Grosvik, H., and Clausen, O.P., 1,25 dihydroxyvi-tamin D3 analogue KH 1060 induces hyperproliferation in normal mouse epidermis, Exp. Dermatol., 1993; 2: 113-120.

68. Gniadecki, R. and Serup, J., Stimulation of epidermal proliferation in mice with 1,25 dihydroxyvitamin D3 and receptor-active 20-epi analogues of 1,25 dihydroxyvitamin D3, Biochem. Pharmacol., 1995; 49: 621-624.

69. Hosomi, J., Hosoi, J., Abe, E., Suda, T., and Kuroki, T., Regulation of terminal differentiation of mouse cultured epidermal cells by 1,25 dihydroxyvitamin D3, Endocrinology, 1983; 113: 1950-1957.

70. Kato, T., Terui, T., and Tagami, H., Topically active vitamin D3 analogue, 1,24 dihydroxycholecalciferol, has an antiproliferative effect on the epidermis of guinea pig skin, Br. J. Dermatol., 1987; 117: 528-530.

71. Kragballe, K., Steijlen, B., Ibsen, H.H., van de Kerkhof, P.C., Esmann, J., Sorensen, L.H., and Axelsen, M.B., Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization, Arch. Dermatol., 1995; 131: 556-560.

van der Kerhof, P.C., Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms, Br. J. Dermatol., 1995; 132: 675-682. Gurlek, A., Pittelkow, M.R., and Kumar, R., Modulation of growth factor/cytokine synthesis and signaling by 1,25 dihydroxyvitamin D3: implications in cell growth and differentiation, Endocrine Rev., 2002; 23: 763-786.

Bao, B.Y., Hu, Y.C., Ting, H.J., and Lee, Y.F., Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells, Oncogene, 2004; 23: 3350-3360.

Eisman, J.A., Barkla, D.H., and Tutto, J.M., Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25 dihydroxyvitamin D3, Cancer Res., 1987; 47: 21-25.

Bower, M., Colston, K.W., Stein, R.C., Hedley, A., Gazet, J.C., Ford, H.T., and Combes, R.C., Topical calcipotriol treatment in advanced breast cancer, Lancet, 1991; 337: 701-702.

Brown, L.F., Dubin, D., Lavigne, L., Logan, B., Dvorak, H.F., and Van de Water, L., Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing, Am. J. Pathol., 1993; 142: 793-801.

Fransson, J. and Hammar, H., Epidermal growth in the skin equivalent, Arch. Dermatol. Res., 1992; 284: 343-348.

Klein, G.L., Langman, C.B., and Herndon, D.N., Vitamin D depletion following burn injury in children: a possible factor in post-burn osteopenia, J. Trauma, 2002; 52: 346-350. Wray, C.J., Mayes, T., Khoury, J., Warden, G.D., and Gottschlich, M., Metabolic effects of vitamin D on serum calcium, magnesium and phosphorus in pediatric burn patients, J. Burn Care Rehab., 2002; 23: 416-423.

Dawson-Hughes, B., Harris, S.S., Krall, E.A., and Dallal, G.E., Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older, N. Engl. J. Med., 1997; 337: 670-676.

Heubi, J.E., Hollis, B.W., Specker, B., and Tsang, R.C., Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism, Hepatology, 1989; 9: 258-264.

Heubi, J.E., Hollis, B.W., and Tsang, R.C., Bone disease in chronic childhood cholestasis. II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia, Pediatr. Res., 1990; 27: 26-31.

Davies, M., Heys, S.E., Selby, P.L., Berr, J.L., and Mawer, E.B., Increased catabolism of 25-hydroxyvitamin D levels. Implications for metabolic bone disease, J. Clin. Endocrinol. Metab., 1997; 82: 209-212.

Gartner, L.M., Greer, F.R., and the Section on Breast Feeding and Committee on Nutrition, Prevention of rickets and vitamin D deficiency. New guidelines for vitamin D intake, Pediatrics, 2003; 111: 908-910.

Bordier, P., Rasmussen, H., Marie, P., Miravet, L., Gueris, J., and Ryckwaert, A., Vitamin D metabolites and bone mineralization in man, J. Clin. Endocrinol. Metab., 1978; 46: 284-294.

Valimaki, V., Alfthan, H., Lehmuskallio, E., Loyttyniemi, E., Sahi, T., Stenman, U., Suominen, H., and Valimaki, M.J., Vitamin D status as a determinant of peak bone mass in young Finnish men, J. Clin. Endocrinol. Metab., 2004; 89: 76-80. Janssen, H.C.J.P., Samson, M.M., and Verbaar, H.J., Vitamin D deficiency, muscle function, and falls in elderly people, Am. J. Clin. Nutr., 2002; 75: 611-615. Rimaniol, J.M., Authier, F.J., and Chariot, P., Muscle weakness in intensive care patients. Initial manifestation of vitamin D deficiency, Intensive Care Med., 1994; 20: 591-592.

90. Vu, D., Ong, J.M., Clemens, T.L., and Kern, P.A., 1,25-dihydroxyvitamin D induces lipoprotein lipase expression in 3T3-L1 cells in association with adipocyte differentiation, Endocrinology, 1996; 1137: 1540-1544.

91. Hypponen, E., Laara, E., Reunanen, A., Jarvelin, M.R., and Virtanen, S.M., Intake of vitamin D and risk of type I diabetes: a cohort study, Lancet, 2001; 358: 1500-1503.

92. Tsoukas, C.D., Provvedini, D.M., and Manolagas, S.C., 1,25 Dihydroxyvitamin D3: a novel immunoregulatory hormone, Science, 1984; 224: 1438-1439.

93. Manolagas, S.C., Provvedini, D.M., and Tsoukas, C.D., Interaction of 1,25-dihydroxy-vitamin D3 and the immune system, Mol. Cell. Endocrinol., 1985; 43: 113-122.

94. Binderup, L., Latini, S., Binderup, E., Bretting, C., Calverley, M., and Hansen, K., 20-epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses, Biochem. Pharmacol., 1991; 42: 1569-1575.

95. Tsai, A.C., Kelley, J.J., Peng, B., and Cook, N., Study on the effect of megavitamin supplementation in man, Am. J. Clin. Nutr., 1978; 31: 831-837.

96. Kitagawa, M. and Mino, M., Effects of elevated D-(RRR)-tocopherol dosage in man, J. Nutr. Sci. Vitaminol., 1989; 35: 133-142.

97. Vieth, R., Chan, P.C.R., and MacFarlane, G.D., Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level, Am. J. Clin. Nutr., 2001; 73: 288-294.

98. Heaney, R.P., Davies, K.M., Chen, T.C., Holick, M.F., Barger-Lux, M.J., Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol, Am. J. Clin. Nutr., 2003; 77: 204-210.

99. Vieth, R., Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety, Am. J. Clin. Nutr., 1999; 69: 842-856.

100. Hayes, K.C. and Hegsted, D.M., Toxicity of the vitamins, in Committee on Food Protection Toxicants Occurring Naturally in Foods, 2nd ed., National Academy of Sciences, Washington, D.C., 1973; 239-242.

101. American Academy of Pediatrics, The prophylactic requirement and the toxicity of vitamin D, Pediatrics, 1963; 31: 512-523.

102. Adams, J.S., Bone density and vitamin D intoxication, Ann. Intern. Med., 1998; 128: 508.

103. Hinder, R.A. and Stein, H.J., Oxygen-derived free radicals, Arch. Surg., 1991; 124: 104-105.

104. Bieri, J.G., Corash, L., and Hubbard, V.S., Medical uses of vitamin E, N. Engl. J. Med., 1983; 308: 1063-1071.

105. Lopez-Torres, M., Thiele, J.J., Shindo, Y., Han, D., and Packer, L., Topical application of -tocopherol modulates the antioxidant network and diminishes ultraviolet-induced oxidative damage in murine skin, Br. J. Dermatol., 1998; 138: 207-213.

106. Tappel, A.L., Free-radical lipid peroxidation damage and its inhibition by vitamin E and selenium, Fed. Proc., 1965; 24: 73-78.

107. Sata, K., Niki, E., and Shimasaki, H., Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C, Arch. Biochem. Biophys., 1990; 279: 402-405.

108. Nguyen, T.T., Cox, C.S., Traber, D.L., Gasser, H., Ridl, H., Schlag, G., and Herndon, D.N., Free radical activity and loss of plasma antioxidants, vitamin E and sulfhydryl groups in patients with burns, J. Burn Care Rehabil., 1993; 14: 602-609.

109. Williams, R.J., Motteram, J.M., Sharp, C.H., and Gallagher, P.J., Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits, Atherosclerosis, 1992; 94: 153-159.

Jurkiewicz, B.A., Bissett, D.L., and Buettner, G.R., Effect of topically applied tocopherol on ultraviolet radiation-mediated free radical damage in skin, J. Invest. Dermatol., 1995; 104: 484-488.

Sasaki, J., Cottam, G.L., and Baxter, C.R., Lipid peroxidation following thermal injury, J. Burn Care Rehabil, 1983; 4: 251-254.

Mingjian, Z., Qifang, W., Lanxing, G., Hong, J., and Zongyin, W., Comparative observation of the changes in serum lipid peroxides influenced by the supplementation of vitamin E in burn patients and healthy controls, Burns, 1992; 18: 19-21. Brigelius-Flohe, R., Kelly, F.J., Salonen, J.T., Neuzil, J., Zingg, J.M., and Azzi, A., The European perspective on vitamin E: current knowledge and future research, Am. J. Clin. Nutr., 2002; 76: 703-716.

Traber, M.G. and Packer, L., Vitamin E: beyond antioxidant function, Am. J. Clin. Nutr., 1995; 62: 1501S-1509.

Rundus, C., Peterson, V.M., Zapata-Sirvent, R., Hansbrough, J., and Robinson, W.A., Vitamin E improves cell-mediated immunity in the burned mouse: a preliminary study, Burns, 1984; 11: 11-15.

Tanaka, J., Fujiwara, H., and Torisu, M., Vitamin E and immune response: I. Enhancement of helper T-cell activity by dietary supplementation of vitamin E in mice, Immunology, 1979; 38: 727-734.

Violi, F., Pratico, D., Ghiselli, A., Alessandri, C., Iuliano, L., Cordova, C., Balsano, F., Inhibition of cyclooxygenase-independent platelet aggregation by low dose vitamin E concentration, Atherosclerosis, 1990; 82: 247-252.

Steiner, M., Influence of vitamin E on platelet function in humans, J. Am. Coll. Nutr., 1991; 10: 466-473.

Baxter, C.R., Immunologic reactions in chronic wounds, Am. J. Surg., 1994; 167(S): 12-14.

Lee, M., An investigation into the value of d-1-tocopherol acetate (vitamin E) in the treatment of gravitational ulcers, Br. J. Dermatol., 1953; 65: 131-138. Taren, D.L., Chvapil, M., and Weber, C.W., Increasing the breaking strength of wounds exposed to preoperative irradiation using vitamin E supplementation, Int. J. Vit. Nutr. Res., 1987; 57: 133-137.

Melkumian, A.S., Tumanian, E.L., and Agadzhanov, M.I., Histological evaluation of the regenerative capacity of the skin in the treatment of burn wounds with a vitamin E based ointment, Zh. Eksp. Klin. Med., 1978; 18: 52-54.

Vandenboer, H., Schmidt, E., Fajardo, C., Buttler, I., Assis, G., and Vianna, L.M., Effect of a-tocopherol on wound healing, Clin. Nutr., 1999; 18: 59. Baumann, L.S. and Spencer, J., The effects of topical vitamin E on the cosmetic appearance of scars, Dermatol. Surg., 1999; 25: 311-315.

Havlik, R.J., Vitamin E and wound healing, Plast. Reconstr. Surg., 1997; 100: 1901-1902.

Palmieri, G., Vitamin E added silicone gel sheets for treatment of hypertrophic scars and keloids, Int. J. Dermatol., 1995; 34: 506-509.

Jenkins, M., Alexander, J.W., MacMillan, B.G., Waymack, J.P., and Kopcha, R., Failure of topical steroids and vitamin E to reduce postoperative scar formation following reconstructive surgery, J. Burn Care Med., 1986; 7: 309-312. Fisher, A.A., Three faces of vitamin E topical allergy, Cutis, 1991; 48: 272-274. Perrenoud, D., Homberger, H.P., Auderset, P.C., Emmenegger, R., Frenk, E., Saurat, J.H., and Hauser, C., An epidemic outbreak of papular and follicular dermatitis to tocopheryl linoleate in cosmetics, Dermatology, 1994; 189: 225-233.

130. Kelly, F.J. and Sutton, G.L.J., Plasma and red blood cell vitamin E status in patients on total parenteral nutrition, JPEN, 1989; 13: 510-515.

131. Kuroiwa, K., Nelson, J.L., Boyce, S.T., Alexander, J.W., Ogle, C.K., and Inoue, S., Metabolic and immune effect of vitamin E supplementation after burn, JPEN, 1991; 15: 22-26.

132. Horwitt, M.K., Critique of the requirement for vitamin E, Am. J. Clin. Nutr., 2001; 73: 1003-1005.

133. Carpenter, D., Vitamin E deficiency, Sem. Neurol., 1985; 5: 283-287.

134. Sokol, R.J., Vitamin E deficiency and neurologic disease, Ann. Rev. Nutr., 1988; 8: 351-373.

135. Farrell, P.M. and Bieri, J.G., Megavitamin E supplementation in man, Am. J. Clin. Nutr., 1975; 28: 1381-1386.

136. Weber, P., Bendich, A., and Machlin, L., Vitamin E and human health: rationale for determining recommended intake levels, Nutrition, 1997; 13: 450-460.

137. Bendich, A. and Machlin, L.J., Safety of oral intake of vitamin E, Am. J. Clin. Nutr., 1988; 48: 612-619.

138. Kappus, H. and Diplock, A.T., Tolerance and safety of vitamin E: a toxicological position report, Free Rad. Biol. Med., 1992; 13: 55-74.

139. Goodson, W.H. and Hunt, T.K., Wound healing, in Nutrition and Metabolism in Patient Care, Kinney, J.M., Jeejeebhoy, K.N., and Hill, G.L., Eds., W.B. Saunders, Philadelphia, 1988: 635-642.

140. de la Rubia, J., Grau, E., Montserrat, I., Zuazu, I., and Paya, A., Anaphylactic shock and vitamin K [letter], Ann. Intern. Med., 1989; 110: 943.

141. Bossee, G.M., Mallory, M.N., and Malone, G.J., The safety of intravenously administered vitamin K, Vet. Hum. Toxicol., 2002; 44: 174-176.

142. Shevchuk, Y.M. and Conly, J.M., Antibiotic-associated hypoprothrombinemia: a review of prospective studies 1966-1988, Rev. Infect. Dis., 1990; 12: 1109-1126.

143. Shearer, M.J., Bechtold, H., Andrassy, K., Koderisch, J., McCarthy, P.T., Trenk, K., Jahnchen, E., and Ritz, E., Mechanism of cephalosporin-induced hypoprothrombine-mia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status, J. Clin. Pharmacol., 1988; 28: 88-95.

144. Rai, K. and Courtemanche, A.D., Vitamin A assay in burned patients, J. Trauma, 1975; 15: 419-424.

145. Cynober, L., Desmoulins, D., Lioret, N., Aussel, C., Hirsch-Marie, H., and Saizy, R., Significance of vitamin A and retinol binding protein serum levels after burn injury, Clin. Chim. Acta, 1985; 148: 247-253.

146. Rock, C.L., Dechert, R.E., Khilnani, R., Parker, R.S., and Rodriguez, J.L., Caro-tenoids and antioxidant vitamins in patients after burn injury, J. Burn Care Rehabil., 1997; 18: 269-278.

147. Szebeni, A., Negyesi, G., and Feuer, L., Vitamin A levels in the serum of burned patients, Burns, 1980; 7: 313-318.

148. Rojas, A.I. and Phillips, T.J., Patients with chronic leg ulcers show diminished levels of vitamins A and E, carotenes, and zinc, Dermatol. Surg., 1999; 25: 601-604.

149. Thomas, M.K., Lloyd Jones, D.M., Thadhani, R.I., Shaw, A.C., Deraska, D.J., Kitch, B.T., Vamvakas, E.C., Dick, I.M., Prince, R.L., and Finkelstein, J.S., Hypovitaminosis D in medical inpatients, N. Engl. J. Med., 1998; 338: 777-783.

150. Freaney, R., McBrinn, Y., and McKenna, M.J., Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency, Am. J. Clin. Nutr., 1993; 58: 187-191.

Jacques, P.F., Felson, D.T., Tucker, K.L., Mahnken, B., Wilson, P.W., Rosenberg, I.H., and Rush, D., Plasma 25-hydroxyvitamin D and its determinants in an elderly population, Am. J. Clin. Nutr., 1997; 66: 929-936.

MacLaughlin, J. and Holick, M.F., Aging decreases capacity of human skin to produce vitamin D3, J. Clin. Invest., 1985; 76: 1536-1538.

Klein, G.L., Horst, R.L., and Norman, A.W., Reduced serum levels of 1,25-dihydroxy-vitamin D during long term total parenteral nutrition, Ann. Intern. Med., 1981; 94: 638-643.

Shike, M., Harrison, J.E., Sturtridge, W.C., Tam, C.S., Bobechko, P.E., Jones, G., Murray, T.M., and Jeejeebhoy, K.N., Metabolic bone disease in patients receiving long term total parenteral nutrition, Ann. Intern. Med., 1980; 92: 343-350. Baer, M.T., Kozlowski, B.W., Blyler, E.M., Trahms, C.M., Taylor, M.L., and Hogan, M.P., Vitamin D, calcium and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status, Am. J. Clin. Nutr., 1997; 65: 1042-1051.

Buckley, L.M., Leib, E.S., Cartularo, K.S., Vacek, P.M., and Cooper, S.M., Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low dose corticosteroids in patients with rheumatoid arthritis, Ann. Intern. Med., 1996; 125: 961-968.

Sambrook, P., Birmingham, J., Kelly, P., Kempler, S., Nguyen, T., Pocock, N., and Eisman, J., Prevention of corticosteroid osteoporosis: a comparison of calcium, cal-citriol, and calcitonin, N. Engl. J. Med., 1993; 328: 1747-1752. Barnes, T.C. and Bucknall, R.C., Vitamin D deficiency in a patient with systemic lupus every thematosus, Rheumatology, 2004; 43: 393-394.

Mayes, T., Gottschlich, M.M., James, L., and Warden, G.D., An evaluation of the relationship between protein status and vitamin D nutriture in burned infants, J. Burn Care Rehabil., 2004; 25: S147.

Cannata-Andia, J.B. and Alonso, C.G., Vitamin D deficiency: a neglected aspect of disturbed calcium metabolism in renal failure, Nephrol. Dial. Transplant, 2002; 17: 1875-1878.

Wilson, L., Felsenfeld, A., Drezner, M.K., and Llach, F., Altered divalent ion metabolism inearly renal failure: role of 1,25(OH)2D, Kidney Int., 1985; 27: 565-573. Rosen, J.F. and Chesney, R.W., Circulating calcitriol concentrations in health and disease, J. Pediatr., 1983; 103: 1-17.

Compston, J.E., Ayers, A.B., Horton, L.W., Tighe, J.R., and Creamer, B., Osteomalacia after small intestinal resection, Lancet, 1978; 1: 9-12.

Lo, C.W., Paris, P.W., Clemens, T.L., Nolan, J., and Holick, M.F., Vitamin D absorption in healthy subjects and in in-patients with intestinal malabsorption syndromes, Am. J. Clin. Nutr., 1985; 42: 644-649.

Vandewoude, M.G., Vandewoude, M.F.J., and DeLeeuw, I.H., Vitamin E status in patients on parenteral nutrition receiving Intralipid, JPEN, 1986; 10: 303-305. Lloyd, J.K., The importance of vitamin E in human nutrition, Acta Pediatr. Scand., 1990; 79: 6-11.

Shukla, A., Rasik, A.M., and Patnaik, G.K., Depletion of reduced glutathione, ascorbic acid, vitamin E and antioxidant defence enzymes in a healing cutaneous wound, Free Radic. Res., 1997; 26: 93-101.

Gupta, A., Singh, R.L., and Raghubir, R., Antioxidant status during cutaneous wound healing in immunocompromised rats, Mol. Cell. Biochem., 2002; 241: 1-7.

169. Jenkins, M.E., Gottschlich, M.M., Kopcha, R., Khoury, J., and Warden, G.D., A prospective analysis of serum vitamin K in severely burned pediatric patients, J. Burn Care Rehabil, 1998; 19: 75-81.

170. Alperin, J.B., Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients, JAMA, 1987; 258: 1916-1919.

171. Shevchuk, Y.M. and Conly, J.M., Antibiotic-associated hypoprothrombinemia: a review of prospective studies 1966-1988, Rev. Infect. Dis., 1990; 12: 1109-1126.

172. Conly, J.M., Ramotar, K., Chubb, H., Bow, E.J., and Louie, T.J., Hyproprothrom-binemia in febrile, neutropenic patients with cancer: association with antimicrobial suppression of intestinal microflora, J. Infect. Dis., 1984; 150: 202-212.

173. Carlin, A. and Walker, W.A., Rapid development of vitamin K deficiency in an adolescent boy receiving total parenteral nutrition following bone marrow transplantation, Nutr. Rev., 1991; 49: 179-183.

174. Allison, P.M., Mummah-Schendel, L.L., Kindberg, C.G., Harms, C.S., Bang, N.U., and Suttie, J.W., Effects of a vitamin K-deficient diet and antibiotics in normal human volunteers, J. Lab. Clin. Med., 1987; 110: 180-188.

175. Bhat, R.V. and Deshmukh, C.T., A study of vitamin K status in children on prolonged antibiotic therapy, Indian Pediatr., 2003; 40: 36-40.

176. Ansell, J.E., Kumar, R., and Deykin, D., The spectrum of vitamin K deficiency, JAMA, 1977; 238: 40-42.

177. Verghese, T. and Beverley, D., Vitamin K deficient bleeding in cystic fibrosis, Arch. Dis. Child, 2003; 88: 553-555.

Was this article helpful?

0 0
Treating Rheumatoid Arthritis With Herbs Spices Roots

Treating Rheumatoid Arthritis With Herbs Spices Roots

Did You Know That Herbs and Spices Have Been Used to Treat Rheumatoid Arthritis Successfully for Thousands of Years Do you suffer with rheumatoid arthritis Would you like to know which herbs and spices naturally reduce inflammation and pain 'Treating Rheumatoid Arthritis with Herbs, Spices and Roots' is a short report which shows you where to start.

Get My Free Ebook

Post a comment